Patients with familial adenomatous polyposis (FAP) are a high-risk group for colorectal cancer (CRC) due to a mutation in adenomatous polyposis coli (APC), a tumor suppressor gene, which causes the development of many intestinal polyps (mainly, adenoma as a precancerous lesion). Here, APC is linked to adenoma.